Daily non-political popular news in brief.

Abnormal fat metabolism underlies heart problems in diabetic patients

Heart disease hits people with diabetes twice as often as people without diabetes. In those with diabetes, cardiovascular complications occur at an earlier age and often result in premature death, making heart disease the major killer of diabetic people. But why is heart disease so prevalent among diabetics.

Read more »

Keywords: abnormal, fat, metabolism, underlies, heart, problems, diabetic, patients, underly, problem, patient

« Previous | Next »

Similar news on "Abnormal fat metabolism underlies heart problems in diabetic patients":

1. Viagra boosts heart performance and may save lives
   07-09-2007 · EurekAlert!
   Researchers at the University of Alberta have shown that Viagra, the popular drug prescribed for erectile dysfunction, can improve heart function and potentially save the lives of people with specific heart problems. Viagra's unexpected benefit has led the U of A researchers to encourage doctors to consider the drug when a patient has a failing right ventricle of the heart, a dire condition for which there are currently no treatments available.
   Similar news · Read more »
   
2. Initiative to improve heart failure care at nation's hospitals makes major gains
   07-23-2007 · EurekAlert!
   A national initiative designed to improve heart-failure patient care in hospitals proved effective at increasing hospital adherence to key quality-of-care performance measures and reducing the length of hospital stays for patients. It also resulted in favorable trends for in-hospital and post-discharge mortality rates.
   Similar news · Read more »
   
3. Physicians with low communication scores on exams more likely to receive complaints from patients
   09-04-2007 · EurekAlert!
   Canadian physicians who score poorly on the patient-physician communication portion of the national licensing examination receive more complaints to regulatory authorities on issues such as communication or quality-of-care problems, according to an article in the Sept. 5 issue of JAMA, a theme issue on medical education.
   Similar news · Read more »
   
4. The missing link between belly fat and heart disease?
   01-21-2008 · EurekAlert!
   Overweight people have a higher risk of heart attacks, strokes and other problems that arise from clogged, hardened arteries. Now, a new study in mice gives the first direct evidence of why this link might exist -- and a tantalizing look at how it might be broken.
   Similar news · Read more »
   
5. Advance in understanding of blood pressure gene could lead to new treatments
   02-04-2007 · EurekAlert!
   Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
   Similar news · Read more »
   
6. Dialysis patients with metabolic syndrome show increased risk for heart disease
   03-07-2007 · EurekAlert!
   A study of kidney dialysis patients found that nearly 70 percent had metabolic syndrome, a set of symptoms that is a predictor of cardiovascular disease, at the time they initiated maintenance dialysis. This information further illuminates the relationship between heart and kidney disease, as dialysis patients are already known to have an elevated risk of cardiovascular problems.
   Similar news · Read more »
   
7. Geisinger launches extensive study on obesity and related liver problem
   04-16-2007 · EurekAlert!
   Geisinger Health System researchers in Danville, Pa., are looking at the genetics of obesity through a unique study. Geisinger patients have voluntarily donated more than 600 liver tissue samples so that researchers can study obesity and also develop a safer, noninvasive way of detecting an obesity-related condition: nonalcoholic fatty liver disease. Relying on several core system resources in the study, Geisinger researchers hope to know more about nonalcoholic fatty liver disease and related health problems.
   Similar news · Read more »
   
8. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
   05-17-2007 · EurekAlert!
   A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions.
   Similar news · Read more »
   
9. Study identifies glucose 'sensor' that plays dual role in glucose metabolism and fat synthesis
   12-26-2006 · EurekAlert!
   In a new study, scientists at the Scripps Research Institute have described for the first time a glucose-activated sensor that acts as a switch to decrease production of endogenous glucose in the liver, and increase conversion of glucose to fat for storage in adipose tissue. This dual action makes the sensor, Liver X Receptor, a potential target for new therapies aimed at obesity and diabetes. The research may also have implications for heart disease and stroke.
   Similar news · Read more »
   
10. Heart attack-related depression puts patients at risk for further cardiovascular emergencies
    11-27-2006 · EurekAlert!
    People who experience their first-ever bout of depression after having a heart attack are at greater risk for future heart problems than are patients who either don’t become clinically depressed after the medical emergency or who were depressed even before the incident, new research shows.
    Similar news · Read more »